Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000216159 | SCV000276550 | likely benign | Hereditary cancer-predisposing syndrome | 2016-03-09 | criteria provided, single submitter | clinical testing | Synonymous alterations with insufficient evidence to classify as benign |
Labcorp Genetics |
RCV000228947 | SCV000284415 | likely benign | Neurofibromatosis, type 1 | 2025-01-08 | criteria provided, single submitter | clinical testing | |
Laboratory for Molecular Medicine, |
RCV000600552 | SCV000712933 | likely benign | not specified | 2017-01-18 | criteria provided, single submitter | clinical testing | p.Arg873Arg in exon 21 of NF1: This variant is not expected to have clinical sig nificance because it does not alter an amino acid residue and is not located wit hin the splice consensus sequence. It has been identified in 1/16512 South Asian chromosomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitu te.org; dbSNP rs766212733). |
Gene |
RCV001537827 | SCV000723067 | likely benign | not provided | 2020-01-02 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV000216159 | SCV002527467 | likely benign | Hereditary cancer-predisposing syndrome | 2020-07-14 | criteria provided, single submitter | curation | |
Genome- |
RCV000228947 | SCV002560575 | likely benign | Neurofibromatosis, type 1 | 2022-03-15 | criteria provided, single submitter | clinical testing |